EGRP NEWS FLASH This News Flash from the Epidemiology and Genetics Research Program (EGRP) provides information about:
Job Opportunities with EGRPEGRP has three job opportunities available for Cancer Research Training Award (CRTA) fellows. The positions are to work on EGRP's:
The candidates must meet basic qualifications for a CRTA appointment: a.) be a U.S. citizen or resident alien; b) be at least 16 years of age; c) provide copy of university transcript, or documentation of enrollment in a doctoral program, or documentation of less than 5 years but no more than 8 years postdoctoral or medical training (specifics vary with position; see EGRP's Web site); and d) provide 1-page statement of interest and experience. The salary range depends on the CRTA category and years of experience. The fellows will work in EGRP's offices in Rockville, Md., which is a suburb of Washington, D.C. Please refer to EGRP's Web site to read the complete advertisements and learn where to send letters of interest, CVs, and names and contact information for references. Direct Cost Limitations Changed for Certain Solicited ApplicationsNIH has revised its policy on direct cost limitations on solicited applications. Applications in response to Program Announcements (PAs) and Requests for Applications (RFAs) that include a limitation on direct costs are to exclude from that limit the facilities and administrative (F&A) costs requested by consortium participants. The F&A costs requested by the consortium will be reflected in the PHS 398 application according to current instructions, and F&A costs awarded under these programs will continue to be awarded under the current practice. However, these consortium F&A costs will not be counted as a direct cost when determining if an applicant is in compliance with a direct cost limitation on a solicited application. This change applies to applications submitted on or after April 30. Direct questions to the Grants Management Specialist listed in the RFA/PA or to the Division of Grants Policy: (301) 435-0949. This revision does not change the NIH policy on acceptance of applications requesting direct costs of $500,000 or more for any one year. NIH requires grant applicants with a requested budget over $500,000 direct costs in any year to contact the appropriate program staff before submitting applications to the NIH Center for Scientific Review (CSR) for peer review. The NIH Guide Notice stipulates that if the requested dollar amount is more than $1.5 million in direct costs in any year, approval must be sought 6 weeks prior to submitting the grant to CSR. However, approval for NCI epidemiology applications must be sought at least 8 weeks prior to submission to CSR to complete the necessary internal processing by the deadline. CSR no longer accepts amended budgets for submissions over $500,000.
FAQs Posted for RFA on Pharmacogenetics Research Network and Knowledge BaseThe Frequently Asked Questions about the Request for Applications (RFA) for open recompetition of the Pharmacogenetics Research Network and Knowledge Base (U01) are now posted on the Web. Investigators who are not current members of the Network are strongly encouraged to respond. EGRP, which is a cosponsor of the RFA, is particularly interested in epidemiologic research of drug responses and effects relevant to cancer in understudied populations of diverse racial and ethnic origin. NCI is a cosponsor through EGRP and the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (DCTD). The Pharmacogenetics Research Network consists of multidisciplinary, collaborative groups of investigators that contribute their data to the publicly available knowledge base PharmGKB, which is an open research tool accessible to all scientists. The research groups in the network have interests across a range of biological processes: drug metabolism, small molecule transport, target receptors, and biological pathways involved in the drug treatment of cardiovascular diseases, asthma, cancer, and depression. Other areas are welcome consistent with the interests of the funding Institutes. The groups are collecting comprehensive, integrated information about specific proteins and gene families important to the field of pharmacogenetics. Letters of intent are due July 19, and applications are due August
19, 2004. Inquiries related to molecular and genetic epidemiology
may be directed to EGRP's J. Fernando Arena, M.D., Ph.D., Clinical and
Genetic Epidemiology Research Branch (CGERB), e-mail: arenaj@mail.nih.gov;
or Kumiko (Kumi) Iwamoto, M.D., Dr.P.H., Analytic Epidemiology Research
Branch (AERB), e-mail: iwamotok@mail.nih.gov.
Funding Opportunities Elsewhere in Our Division
Funding Opportunities Elsewhere at NCI
Small Business Programs Conference at NIH on June 23-24On June 23-24, NIH will host its annual conference focusing on funding opportunities available through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs for small businesses that have innovative biomedical or behavioral research ideas with commercial potential. The conference is to benefit those who are relatively new to the Programs, as well as those who are more experienced. The conference will be held at the Natcher Conference Center, NIH Campus, Bethesda, Md. Registration is free but mandatory, and space fills quickly. Read more about the conference and register online. In the SBIR Program, funding is usually provided for up to 6 months and $100,000 total cost for Phase I feasibility studies, and for up to 2 years and $750,000 for Phase II projects. The STTR Program requires close collaboration between the small business and a partnered research institution. The small business is to conduct at least 40% of the research project, and the single, partner institution conducts at least 30% of the work. Funding is usually provided for up to 1 year and $100,000 total cost for Phase I feasibility studies, and for up to 2 years and $750,000 for Phase II projects.
Highlights of Research by EGRP GranteesWe now have a section on our Web site with highlights of research conducted and published by grantees supported through EGRP. Our investigators are very productive, and we can't begin to do justice to all the research. We welcome your suggestions on additions. Contact Linda Anderson, EGRP Communications Director; e-mail: andersoL2@mail.nih.gov. Steps Taken to Protect EGRP ListServ From Being SpoofedRecently a hacker gained access to EGRP's ListServ e-mail address, "Friends-of-NCI-EGRP-L," to send an attachment that may have contained a virus. In computer lingo, it's called "spoofing." There was no message in the body of the e-mail, only the attachment. Some of our readers let us know that their computer security systems deleted the attachment or flagged it as suspicious. A few people opened the attachment but did not encountering problems, which may be because the NIH computer security experts have in place systems to try and strip viruses that may be attached to outgoing messages. We've now set up an extra level of protection with the help of the NIH ListServ staff. After we send an e-mail message to the ListServ for distribution, a message will be returned asking us to confirm that the communication is truly from us before it will be sent. In addition, if we have any attachments to share with you, we will post them on our Web site and let you access them from there. Subscribe to Receive EGRP Bulletins and News FlashesYou are welcome to tell others about EGRP's ListServ through which we send occasional Bulletins and News Flashes about funding opportunities, resources, and activities of potential interest to researchers and administrators working in cancer epidemiology. To subscribe, contact Linda Anderson; e-mail: andersoL2@mail.nih.gov. |